Sangamo loses Nasdaq listing appeal after minimum bid price breachPUBT·Jul 20 at 03:45 PMSGMOQ+3.34%SGMO0.00%
Sangamo Therapeutics ends Ernst & Young as auditor after Chapter 11 filingPUBT·Jul 1 at 03:01 PMSGMOQ+3.34%
Sangamo Bankruptcy Puts Gene Therapy Platforms In Play, Eli Lilly And Astellas Circlebenzinga_article·Jun 23 at 12:46 PMSGMO0.00%ALPMY+3.37%
Sangamo Therapeutics Sets Stalking Horse Sales: $50M to Eli Lilly, Up to $50M to AstellasTradingView·Jun 23 at 07:53 AMSGMO0.00%ALPMY+3.37%
Sangamo lines up up to $30 million debtor-in-possession loan from Northridge ATM amid Chapter 11 filingPUBT·Jun 23 at 07:47 AMSGMO0.00%SGMOQ+3.34%
Sangamo Therapeutics files for Chapter 11 as Lilly, Astellas anchor asset sale bidsPUBT·Jun 23 at 07:05 AMSGMO0.00%LLY-4.55%
Deal Dispatch: Carlyle Buys Chung Ho Group, Second Nature Brands Acquires Tillamook Country Smoker, GoHealth Bankruptcybenzinga_article·Jun 12 at 01:40 PMKALV0.00%ZOOZ+2.29%
Sangamo Therapeutics Announces Exploration of Strategic Alternatives to Maximize Value for Stakeholders | SGMO Stock NewsStockTitan·Jun 7 at 11:05 PMSGMO0.00%SGMOQ+3.34%
Sangamo Therapeutics Reports No Unregistered Equity Sales or Share Repurchases for the PeriodTip Ranks·May 16 at 01:01 AMSGMO0.00%FBT+0.87%
Full Transcript: Sangamo Therapeutics Q1 2026 Earnings Callbenzinga_article·May 14 at 04:00 PMSGMO0.00%XBI+2.40%
Sangamo Therap | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 1.442 MEarnings Watch·May 14 at 03:09 PMSGMO0.00%SGMOQ+3.34%
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga_article·Apr 29 at 12:05 PMSGMO0.00%DSGN+4.99%
H.C. Wainwright Reaffirms Their Buy Rating on Sangamo Therapeutics (SGMO)Tip Ranks·Apr 29 at 05:41 AMSGMO0.00%FBT+0.87%
Sangamo Therapeutics Announces Transition to Trading on OTCQB Venture Market | SGMO Stock NewsStockTitan·Apr 28 at 11:05 PMSGMO0.00%PBE-3.00%
